Skip to main content
Top

Journal of Cancer Research and Clinical Oncology

Issue 6/2008

Content (13 Articles)

Original Paper

A logistic regression model for predicting malignant pheochromocytomas

Baohua Gao, Yanxia Sun, Zhongguo Liu, Fanwei Meng, Benkang Shi, Yuqiang Liu, Zhishun Xu

Original Paper

Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India

Leelakumari Sreeja, Volga S. Syamala, Vani Syamala, Sreedharan Hariharan, Praveenkumar B. Raveendran, R. V. Vijayalekshmi, Jayaprakash Madhavan, Ravindran Ankathil

Original Paper

Kaposi’s sarcoma after liver transplantation

Fabrizio Di Benedetto, Stefano Di Sandro, Nicola De Ruvo, Massimiliano Berretta, Michele Masetti, Roberto Montalti, Roberto Ballarin, Stefania Cocchi, Leonardo Potenza, Mario Luppi, Giorgio E. Gerunda

Original Paper

The value of combined use of survivin, cytokeratin 20 and mucin 7 mRNA for bladder cancer detection in voided urine

Xiao-Yong Pu, Zhi-Ping Wang, Yi-Rong Chen, Xing-Huan Wang, Yi-Long Wu, Huai-Peng Wang

Original Paper

Clinical efficacy of all-trans retinoic acid for treating adult T cell leukemia

Yasuhiro Maeda, Terufumi Yamaguchi, Yasuki Hijikata, Miyako Tanaka, Chikara Hirase, Shunsuke Takai, Yasuyoshi Morita, Tetsuaki Sano, Jun-ichi Miyatake, Yoichi Tatsumi, Akihisa Kanamaru

Original Paper

Synergistic antitumor effect of CXCL10 with hyperthermia

Ping Chen, Ling-lin Yang, Han-shuo Yang, Yong-sheng Wang, Gang Li, Yang Wu, Fang Fang, Kang Liu, Jie Li, Xia Zhao, Huo-zhen Hu, Yu-quan Wei

Original Paper

Paclitaxel (Taxol®)-induced apoptosis in human epithelioid sarcoma cell lines is enhanced by upregulation of CD95 ligand (FasL/Apo-1L)

Sebastian Heikaus, Krystian S. Matuszek, Christoph V. Suschek, Uwe Ramp, Petra Reinecke, Edgar Grinstein, Janine Haremza, Helmut E. Gabbert, Csaba Mahotka

Original Paper

Targeting c-KIT, PDGFR in cancer of unknown primary: a screening study for molecular markers of benefit

L. Dova, G. Pentheroudakis, V. Golfinopoulos, V. Malamou-Mitsi, I. Georgiou, G. Vartholomatos, A. Ntemou, G. Fountzilas, N. Pavlidis

Original Paper

Histopathological assessment of anastrozole and tamoxifen as preoperative (neoadjuvant) treatment in postmenopausal Japanese women with hormone receptor-positive breast cancer in the PROACT trial

Masafumi Kurosumi, Yuichi Takatsuka, Toru Watanabe, Shigeru Imoto, Hideo Inaji, Hitoshi Tsuda, Futoshi Akiyama, Goi Sakamoto, Tadashi Ikeda, Shinzaburo Noguchi

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.